Molecules · 2020 · 25 citations · 27 references
MedicineMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyAnthelmintic PharmacologyAntibacterial AgentsAntibacterial PharmacologyAntiparasitic AgentsAntiparasitic PharmacologyInsect PathogensDose-dependent InfectionLarval Development AssayMycobacterium Tuberculosis InfectionTherapeutic Efficacy Assessment
Among four mycobacteria, Mycobacterium avium, M. intracellulare, M. bovis BCG and Mycobacteroides (My.) abscessus, we established a silkworm infection assay with My. abscessus. When silkworms (fifth-instar larvae, n = 5) were infected through the hemolymph with My. abscessus (7.5 × 107 CFU/larva) and bred at 37 °C, they all died around 40 h after injection. Under the conditions, clarithromycin and amikacin, clinically used antimicrobial agents, exhibited therapeutic effects in a dose-dependent manner. Furthermore, five kinds of microbial compounds, lariatin A, nosiheptide, ohmyungsamycins A and B, quinomycin and steffimycin, screened in an in vitro assay to observe anti-My. abscessus activity from 400 microbial products were evaluated in this silkworm infection assay. Lariatin A and nosiheptide exhibited therapeutic efficacy. The silkworm infection model with My. abscessus is useful to screen for therapeutically effective anti-My. abscessus antibiotics.
27
Kevin A. Nash, Barbara A. Brown‐Elliott, Richard J. Wallace · Antimicrobial Agents and Chemotherapy · 2009 · 644 citations · Full text
Silkworm larvae as an animal model of bacterial infection pathogenic to humans
Chikara Kaito, Nobuyoshi Akimitsu, Haruo Watanabe et al. · Microbial Pathogenesis · 2002 · 263 citations · Full text